SAFit2 |
SAFit2 : Antagonist of FKBP5
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download
Probe Summary
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| FKBP5 |
|
|
Antagonist
up to 5 µM
Selectivity
In Vitro Selectivity Assessment
Potency Assay Off-Target:
Selectivity within target family:
Competitive fluorescence polarization assay: FKBP1B (Kd = 38.9 ± ...
In Cell Selectivity Assessment
Potency Assay Off-Target:
NanoBRET assay (HEK293T cell line FKBP51-NLuc): FKBP1A (IC50 = 1103 ± 86 nM)
Potency Cellular
In Vitro
FKBP5
Mode of Action: Antagonist
Structure-Activity-Relationship data available? Yes
DOI Reference: 10.1021/acs.jmedchem.5b01355
In Vivo Validations
Mouse
Dose: 10 mg/Kg
Route of delivery:
Intraperitoneal
Plasma half life:
9.2 h
Cmax:
2094.8 ng/ml
Tmax:
0.3 h
Area Under the Curve::
7117.0 h*ng/ml
Target engagement assay:
Brain:plasma ratio: 16.7%
DOI Reference: 10.1038/nchembio.1699
Negative Control Compounds
ddSAFit2
Notes: ddSAFit2: Kd > 20 μM (FP assay)
SMILES:
COc1ccc(CC[C@H](c2cccc(c2)OCCN2CCOCC2)OC([C@H]2CCCCN2C([C@H](C2CCCCC2)c2cc(c(c(c2)OC)OC)OC)=O)=O)cc1OC
Chemical Information
| Molecular Formula | C46H62N2O10 |
| SMILEs | COc1ccc(CC[C@@H](OC(=O)[C@@H]2CCCCN2C(=O)[C@H](c2cc(OC)c(OC)c(OC)c2)C2CCCCC2)c2cccc(OCCN3CCOCC3)c2)cc1OC |
| InChI | InChI=1S/C46H62N2O10/c1-51-39-20-18-32(28-40(39)52-2)17-19-38(34-14-11-15-36(29-34)57-27-24-47-22-25-56-26-23-47)58-46(50)37-16-9-10-21-48(37)45(49)43(33-12-7-6-8-13-33)35-30-41(53-3)44(55-5)42(31-35)54-4/h11,14-15,18,20,28-31,33,37-38,43H,6-10,12-13,16-17,19,21-27H2,1-5H3/t37-,38+,43-/m0/s1 |
| Molecular weight | 802.44 Da |
| AlogP | 7.4029 |
| HBond acceptors | 12 |
| HBond donors | -- |
| Atoms | 120 |